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'The gastrointestinal tract represents the first barrier against food contaminants as well as the first target for
these toxicants. Deoxynivalenol (DON) is amycotoxin that commonly contaminates cereals and causes various
toxicological effects. Through consumption of contaminated cereals and cereal products, human and pigs are
exposed to this mycotoxin. Using in vitro, ex vivo and in vivo approaches, we investigated the effects of DON on
the intestinal epithelium. We demonstrated that, in intestinal epithelial cell lines from porcine (IPEC-1) or
human (Caco-2) origin, DON decreases trans-epithelial electrical resistance (TEER) and increases in a time and
dose-dependent manner the paracellular permeability to 4 kDa dextran and to pathogenic Escherichia coli
across intestinal cellmonolayers. In pig explants treatedwithDON,we also observed an increased permeability
of intestinal tissue. These alterations of barrier function were associated with a specific reduction in the
expression of claudins, which was also seen in vivo in the jejunum of piglets exposed to DON-contaminated
feed. In conclusion, DON alters claudin expression and decreases the barrier function of the intestinal
epithelium. Considering that high levels of DON may be present in food or feed, consumption of DON-
contaminated food/feed may induce intestinal damage and has consequences for human and animal health.
Introduction
Food safety is a major issue in Europe. In this respect, much
attention needs to be paid to the possible contamination of food by
fungi and the risk of toxin production. Mycotoxins are secondary
metabolites produced by fungi that may contaminate all stages of the
food chain. Their global occurrence is regarded as an important risk
factor for human and animal health as up to 25% of the world crop
production may be contaminated with mycotoxins (Oswald et al.,
2005). In human, the toxicological syndromes caused by ingestion of
mycotoxins range from death, induction of cancer and growth
impairment (Bryden, 2007). Consumption of fungal toxins may also
decrease resistance to infectious diseases (Oswald et al., 2005).
Deoxynivalenol (DON) is a mycotoxin of the trichothecenes family
that is mainly produced by Fusarium graminearum and F. culmorum.
DON is commonly detected in cereals and grains, particularly in
wheat, barley, maize and their by-products. It is the most prevalent
contaminating trichothecene in crop production in Europe and North
America (CAST, 2003; SCOOP, 2003; Pestka and Smolinski, 2005).
Recent surveys including 11,022 cereals samples from 12 European
countries indicated that 57% of the samples were positive for DON
contamination (SCOOP, 2003). Similarly, a survey including 630
samples collected in 25 states by the Federal Grain Inspection Service
in United States, revealed that about 40% of the wheat samples and
57% of the barley samples contained levels greater than 2 mg/kg
(Trucksess et al., 1995). Furthermore, this toxin is resistant to milling,
processing and heating and, therefore, readily enters the food chain
(Sugita-Konishi et al., 2006).Widespread human exposure to DON has
also been demonstrated using a glucuronide metabolite as a urinary
biomarker (Turner et al., 2008).
DON exhibits toxic effects in humans as well as in all animal
species investigated so far (Pestka and Smolinski, 2005). Acute high
dose toxicity of DON is characterized by effects such as diarrhea,
vomiting, leukocytosis, hemorrhage, circulatory shock and ultimately
death. Chronic low dose toxicity is characterized by anorexia, reduced
weight gain, nutrients malabsorption, neuroendocrine changes and
immunologic alterations (Pestka and Smolinski, 2005; Pinton et al.,
2008). At the cellular level DON interacts with the peptidyltransferase
at the 60S ribosomal subunit level, triggering a translational arrest
(Pestka et al., 2004). As a result, protein synthesis is impaired, but also
a so-called “ribotoxic stress” is induced (Pestka et al., 2004), resulting
in the activation of mitogen-activated protein kinases.
The intestinal tract represents the first barrier to ingested
chemicals or food contaminants and is also the first line of defense
against intestinal infection. The gut barrier is formed to a large extent
by tight junctions that seal the luminal end of the intercellular space
and limit transport by this paracellular route to relatively small
hydrophilic molecules. These are multiple transmembrane, scaffold-
ing and signaling proteins including Zonula Occludens-1 (ZO-1),
occludin, and one or more claudin isoforms (Harhaj and Antonetti,
2004). Following ingestion of mycotoxin-contaminated food, intest-
inal epithelial cells could be exposed to high concentrations of toxin
(Maresca et al., 2002; Bouhet and Oswald 2005; Sergent et al., 2006).
However the effects of DON on the gastrointestinal tract have been
poorly studied. DON was found to interfere with the TEER of human
intestinal Caco-2 cells (Kasuga et al., 1998; Sergent et al., 2006) and to
affect nutrients absorption (Maresca et al., 2002).
Using in vitro, ex vivo and in vivo approaches, the aims of the
present study was to evaluate whether doses of DON commonly seen
in contaminated food, could affect the barrier function of the intestine.
We evaluated the effects of DON on (i) trans-epithelial electrical
resistance, (ii) paracellular permeability and (iii) expression of tight
junction proteins.
Materials and methods
Cell culture and reagents. The Caco-2 and IPEC-1 cell lines were
derived from a human colon adenocarcinoma (ATCC HTB-37,
Rockville, USA) and the small intestine of a newborn unsuckled piglet
(Gonzalez-Vallina et al., 1996; Bouhet et al., 2004) respectively. Caco-2
were grown in DMEM medium (Sigma, St Quentin Fallavier, France)
supplemented with penicillin (100 UI/mL), streptomycin (100 μg/
mL), 15% fetal bovine serum (Eurobio, Les Ulis, France), 2 mM L-
glutamine (Eurobio), MEM non-essential amino acids (Sigma). The
same medium was used during the differentiation process. IPEC-1
were grown and differentiated as previously described (Bouhet et al.,
2004). Both cell lines were maintained by serial passages.
Purified DON (Sigma)was dissolved in DMSO and stored at−20 °C
before dilution in cell culture media. Control samples were treated
with DMSO.
Animals. Animal experimentations were carried out in accordance
with European Guidelines for the Care andUse of Animals for Research
Purposes. Crossbred piglets, fed ad libitum with free access to water
were killed by electrocution and exsanguination. Six animals
(15–20 kg) fed with mycotoxin-free diet were used for the Ussing
chamber experiments. Evaluation of claudin-4 expression was
performed on 10 growing pigs fed for 5 weeks with either
mycotoxin-free diet or DON-contaminated diet (2.85mgDON/kg feed).
Measurement of trans-epithelial electrical resistance (TEER). Caco-2
or IPEC-1 cells were seeded at 105 cells in 0.3 cm2 polyethylene
terephtalate membrane inserts with 0.4 μm pore size (Becton
Dickinson, Pont de Claix, France) in culture media and reached
confluence within 2 days. Differentiation media was then used and
changed every other day until complete differentiation. When
differentiated, cells were treated with 0, 10, 20, 50 and 100 μM
(Caco-2 cells) and 0, 10, 20, and 50 μM (IPEC-1 cells) DON and the
TEER was measured during 14 days with a Millicell-ERS
Voltohmmeter (Millipore, Saint-Quentin-en-Yvelines, France). TEER
values were expressed as kΩ×cm2.
Cytotoxicity assay. The cytotoxic effect of DON on Caco-2 or IPEC-1
cells was evaluated by measuring the activity of lactate dehy-
drogenase (LDH) released in the culture media using the CytoTox-
96® Assay Kit (Promega, Charbonnières, France). Indeed, release of
LDH correlates with the number of lysed cells and is widely used in
cytotoxicity studies (Bouhet et al., 2004). Briefly, Caco-2 and IPEC-1
cells were seeded in 0.4 μm pore inserts and differentiated as
described above before adding 0–100 μM DON for 48 h. LDH activity
was then measured according to the manufacturer's instructions.
Paracellular tracer flux assay. Caco-2 or IPEC-1 were grown and
differentiated in 0.4 μm pore inserts and treated with DON for 48 h as
described above. 4 kDa Fluorescein isothiocyanate-dextran (FITC-
dextran) (Sigma) was dissolved in cell culture medium and used at a
final concentration of 2.2 mg/mL in the apical cell compartment. After
1 h of incubation the amount of fluorescence was measured in the
basal compartment with a fluorimeter (Perkin Elmer LS50B,
Courtaboeuf, France). The excitation and emission wavelengths were
490 and 520 nm, respectively.
Bacterial translocation. IPEC-1 cells, seeded in 3 μm pore inserts,
were differentiated and treated for 48 h with DON in antibiotic-free
medium. 24 h later, 2×106 colony forming unit of the pathogenic
Escherichia coli strain 28C (CIP 107983 (Oswald et al., 2003)) was
inoculated onto the apical surface of the cell layer. At various time
points, 100 μL were collected in the basolateral compartment, diluted
1:1 in PBS and plated on Luria Broth Agar (Sigma).
Measurement of paracellular passage of FITC-dextran across porcine
intestinal explants. The intestinal tract was removed and 10-cm
segments from the mid-jejunum were immediately kept at 4 °C in a
Krebs–Henseleit buffer (Sigma). After longitudinal incision, the
underlying serosal andmuscular layers were stripped off, and epithelial
layer were mounted in Ussing chambers (exposed area, 0.5 cm2).
Intestinal explants were equilibrated for 10 min in Krebs–
Henseleit buffer at 38 °C continuously gassed with carbogen (95%
O2, 5% CO2) before adding DON in the mucosal compartment (final
concentration 0–50 μM). Afterwards 500 μL of FITC-dextran was
added to the mucosal side. 800 μL samples were taken from the
serosal side of the chambers 1 to 8 h after the addition of DON and
replaced in the chambers after fluorescence measurements (as
described above).
Confocal immunofluorescence microscopy. Caco-2 and IPEC-1 cells,
seeded in inserts (0.3 cm2, 0.4 μmpores), were differentiated and treated
for 48 h with 30 μM DON. Cells were fixed with PBS 3.7% formaldehyde
(30 min, room temperature) or for claudin-3 with methanol (5 min,
−20°C), permeabilizedwithPBS0.5%Triton-X-100 for3min, andblocked
with 10% goat serum (30 min, room temperature). Samples were
incubated (1 h, room temperature) with anti-human primary antibodies
diluted 1:100. These were rabbit polyclonal anti-claudin-3 (Z23.JM),
occludin (Z-T22) and ZO-1 (Z-R1) or mouse monoclonal anti-claudin-4
(3E2C1) (Zymed Laboratories, South San Francisco, CA, USA). We first
verified that these antibodies cross-reactedwithporcine IPEC-1 cells. Cells
werewashedwithPBS0.1%Tween®20 (v/v)and incubated (30min, room
temperature) with FITC-conjugated goat anti-rabbit (Southern Biotech,
Birmingham, AL, USA) or FITC-conjugated goat anti-mouse (Sigma)
diluted 1:100. After washing, inserts were mounted with Vectashield
(Vector Laboratories, Burlingame, CA, USA). Imageswere captured using a
laser scanning confocal microscope (Olympus-IX70, Rungis, France).
Optical sections (0.5 μm) were obtained using Olympus FV500 FluoView
Application Software. To compare the expressionof tight junctionproteins
in control and treated cells, images were acquired using constant
acquisition parameters (laser power, confocal aperture, photomultipliers
voltage and gain).
Immunohistochemistry. Jejunum fragments (1 cm) obtained from
control and DON-treated animals were rinsed in PBS, fixed in 4%
neutralized formalin for 24 h, embedded in paraffin-wax, cut into 5-μm-
thick sections and deparaffinized. Immunohistochemical staining for
claudin-4 was performed using a standard streptavidine peroxydase
procedure (apparatus Autstainer plus, Dako, France). To suppress
endogenous peroxydase-like enzyme activities (undesirable background
staining), the histological slideswere treated byH2O2, after pretreatment
for epitope retrieval (citrate buffer, ph 6, 95 °C, 40min) and blockedwith
10% goat serum (20 min, room temperature). After phosphate-buffered
saline (PBS) wash, the samples were incubated (50 min, room
temperature) with the primary antibody, a mouse anti-claudin 4, clone
3E2C1, diluted 1:100 (Zymed Laboratories). Sections were washed again
with PBS 0.1% Tween®20 (v/v) and incubated (25 min, room
temperature) with a biotinylated secondary antibody (kit ABC, Dako,
France). After a wash, ABC complex was applied for 25 min at room
temperature (streptavidine peroxidase biotinylated (Dako, France). After
2 PBS washes, 3-3′ diaminobenzidine was applied for 10 min at room
temperature as a chromogen (Dako). The sections were then washed in
distilled water and counterstained with Mayer hematoxylin. Intestinal
sections from control and DON-treated animals were stained in parallel.
Tissue and cell protein extraction, SDS-PAGE, and immunoblotting.
Caco-2 and IPEC-1 cells seeded in inserts (4.2 cm2, 0.4 μm pore) were
differentiated and treated with 30 μM DON during 48 h to analyze
tight junction protein. Cells were rinsed with PBS and scraped in 80 μL
of sample buffer (200 mM Tris–HCl pH 6.8, 30% glycerol, 15% β-
mercaptoethanol, 6% SDS, 0.3% bromophenol blue). The samples were
sonicated for 15 s, heated at 100 °C for 10min and centrifuged (5000 g,
10 min). Supernatant were collected and proteins were quantified
(Schaffner and Weissmann, 1973).
Midjejunal tissue specimens (1 cm) obtained from control or DON-
treated animals were frozen in liquid nitrogen. Frozen tissue were
washed in an anti-protease cocktail (4-(2-Aminoethyl; benzenesulfo-
nyl fluoride hydrochloride; Aprotinin; Leupeptine; Antipaïne; Pepsa-
tine A; Benzamidine, Sigma) prepared in PBS-EGTA (0.25 M). The
samples were then lysed on ice in a Potter tissue grinder with lysis
buffer (20 mM Tris–HCL pH8, 5 mM EDTA, 0.02% NaN3, 1% Triton
X100) supplemented with antiproteases. Solution was homogenized
through a 26G needle and sonicated for 3 times 20 s. Homogenatewas
diluted 1/2with sample buffer (described above) and heated at 100 °C
for 10 min before protein quantification.
15 μg of total proteins from cells or tissues was separated by SDS-
PAGE and transferred onto nitrocellulosemembranes. Themembranes
were blocked with PBS-Tween 5% skimmed milk and incubated with
rabbit anti-claudin-3, mouse anti-claudin-4 (Zymed Laboratories) and
rabbit anti-β-actin (Cell-Signaling, Danvers, MA) antibodies diluted
1:200, 1:500 and 1:2000 in PBS-Tween-milk respectively. After
washing, they were incubated with 1:10,000 horseradish peroxi-
dase-conjugated anti-mouse IgG (detection of claudin-4) or with
1:5000 to 1:7000 horseradish peroxidase-conjugated anti-rabbit IgG
(detection of claudin-3 and β-actin). Antibody binding was detected
with the SuperSignal West Pico chemiluminescent substrate (Pierce,
Brebières, France) after placing the membrane against Hyperfilm™
(Amersham Biosciences, Buckinghamshire, UK). Signal intensities
were estimated using Molecular-Imager® Gel Doc™ and Quantity
One® software (Biorad, Marne la Coquette, France).
Statistical analysis. Data were analyzed with Statview software 5.0
(SAS Institute Inc, Cary, NC) using Student's t and Chi-2 tests. P
valuesb0.05 were considered significant.
Results
DON causes a reduction in TEER of intestinal epithelial cell monolayers
First, we assessed, over a 14-day period, the effects of DON on TEER
of polarized epithelial cells from human and porcine origin. When
DON was added on human intestinal cells (Fig. 1A), a time and dose
dependant reduction of the TEER was observed. After 2 days of
treatment of Caco-2 cells with 5 or 20 μM DON, TEER was slightly
decreased (−7%) but the decrease reached 58% after treatment with
100 μM DON. At the end of the experiment, 14 days of exposure to
DON, the TEER decrease reached 19, 29, 77 and 79% for cells treated
with 5, 10, 50 and 100 μM DON respectively.
A time-and-dose dependant reduction of TEER was also observed
in porcine intestinal epithelial cells exposed to DON (Fig. 1B). One day
of treatment of IPEC-1 cells with DON already induced a significant
decrease of the TEER values:−25% (10 μM) to 60% (50 μM). At the end
of the experiment, the TEER decrease reached 58, 69, 75 and 97% for
cells treated with 5, 10, 20 and 50 μM DON respectively.
To determine whether the reduction in TEER induced by DON was
due to cell death, the effect of 0–50 μM DON on the viability of the
Caco-2 and IPEC-1 cell monolayers was examined using the LDH
release assay. These concentrations of toxin did not significantly alter
the cell viability up to 48 h after treatment (data not shown).
However, exposure to higher concentrations of toxin (200 μM in IPEC-
1 cells and 500 μM in Caco-2 cells) resulted in decrease cells viability.
These results indicate that non-cytotoxic doses of DON decrease
the TEER of human and porcine intestinal cells in a dose and time
dependant manner.
DON increases the permeability of epithelial intestinal cell monolayers
to FITC-dextran and bacteria
Changes in TEER are indicative of alterations in epithelial barrier
function or in the transcellular permeability of ions. To address the
physiological significance of TEER decrease in polarized monolayers,
Fig. 1. Effect of DON on trans-epithelial electrical resistance (TEER) in polarized
intestinal epithelial cell monolayers. Human Caco-2 cells (panel A) or porcine IPEC-1
cells (panel B) were grown and differentiated on inserts then at day 0 various
concentrations of DON were added in the apical compartment: untreated inserts (◊),
inserts treated with 5 (♦), 10 (▪), 20 (▴), 50 (●) or 100 ( ) μMof DON. TEER values are
expressed in kΩ×cm2 as mean±SEM of 4 to 7 independent experiments. Student's
t-tests were performed to determine the effect of DON treatment:⁎Pb0.05.
we tested whether DON also impacts on cell permeability. We first
studied the effects of DON on permeability to FITC-dextran. Caco-2
and IPEC-1 monolayers were treated for 48 h with 0–50 μM DON
before adding FITC-dextran in the apical compartment; one hour later,
the fluorescence intensity was measured in the basolateral compart-
ment. Untreated Caco-2 inserts were not readily permeable to FITC-
dextran; however, upon 48 h treatment with 50 or 100 μM DON, the
monolayer became significantly more permeable with a 1.6 and 4-fold
increase in the tracer flux respectively (Table 1). In IPEC-1monolayers,
DON exposure also caused a dose-dependent increase of the tracer
flux from 1.6 to 3.7-fold for treatment with 5 μM and 20 μM DON
respectively (Table 1). As already observed in TEER experiments, Caco-
2 cells exhibited a lower sensitivity to DON on the permeability of a
paracellular tracer compared to IPEC-1 cells.
We next studied the effect of DON on bacterial translocation on
porcine IPEC-1 cells as they appearedmore sensitive than human cells.
IPEC-1 cells were treated for 48 h with 0–50 μMDON, then E. coliwere
added on the apical side of the insert. Following 1–4 h interaction,
media was collected from the basolateral compartment and plated to
assess bacterial translocation. DON treatment resulted in a time- and
dose-dependent increase of bacterial translocation (Fig. 2). For
example, after 2 h, no bacteria were found in the basolateral medium
of the 6 control inserts, whereas translocation was observed in 17, 50,
63% of inserts treated with 5, 10 and 20 μM DON respectively. At this
time point, bacteria were also found in the basal compartment of all
inserts treated with 50 μM.
These findings demonstrate that, in intestinal epithelial cells, DON
modulates the paracellular pathway leading to an increased passage of
macromolecule and bacteria.
DON increases paracellular passage of FITC-dextran across intestinal
explants
Porcine intestinal explantsmounted in Ussing chamberswere used
to investigate whether the effect of DON on paracellular passage of
FITC-dextran was not limited to the cell culture insert model. These
explants were treated for up to 2 hwith 0–50 μMDON and the passage
of FITC-dextran was measured. As shown in Table 2, a basal
paracellular passage of FITC-dextran was observed in untreated
explants and it increased over time. When the intestinal explants
were treated with 5 μM DON, no significant difference in paracellular
passage was observed compared to control explants. In contrast, the
paracellular passage of FITC-dextran was increased 2 fold in explants
treated with 20 μM and 50 μM DON, when compared to untreated
ones.
DON selectively affects the expression of tight junction proteins
The gut barrier is formed to a large extent by tight junctions
formed by multiprotein complexes that link adjacent epithelial cells
near their apical border. Thus, we next examined the effect of DON on
the expression of several tight junction proteins located in different
cellular compartments: ZO-1 interacting in cytoplasm with actin
cytoskeleton and occludin, claudin-3 or 4 interacting throughout their
extracellular domain with neighbouring cells (McLaughlin et al.,
Table 1
Effect of DON on paracellular flux of FITC-dextran in polarized human or porcine
intestinal epithelial cell monolayers.
Treatment Mean fluorescence intensity measured in different
cell lines
Caco-2 IPEC-1
Control 5.37±0.25 1.36±0.14
5 μM DON 5.80±0.17 2.23±0.31
10 μM DON 6.69±0.58 2.73±0.34
20 μM DON 6.73±0.40 5.09±1.04⁎
50 μM DON 8.37±0.30 ⁎⁎ 166.64±42.01⁎⁎
100 μM DON 21.48±1.51 ⁎⁎ nd
Cell monolayers were grown and differentiated on inserts and treated with different
concentrations of DON during 48 h. FITC-dextran was then added in the apical
compartment. After 1 h, the fluorescent intensity was measured in the basolateral
compartment. Results are expressed as mean fluorescence intensity in the basolateral
compartment after subtraction of the background in 5 independent experiments±
SEM. nd: not done.
DON-treated and control cells were compared with Student t-test: ⁎Pb0.05; ⁎⁎Pb0.01.
Fig. 2. Effect of DON on bacterial translocation across intestinal cell monolayers. IPEC-1 cells were grown and differentiated on 3 μm pore inserts and treated for 48 h with 0 to 50 μM
DON. Pathogenic E. coli were added on the apical side and, at indicated time, samples from the basal compartment were plated. Data are expressed as % inserts where translocation
was observed (numbers inside bars indicate number of insert positive for bacterial translocation compared to the total number of epithelial preparations observed). Chi-2 tests were
performed to determine the effect of DON treatment on bacterial translocation: ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.001.
Table 2
Effect of DON on paracellular passage of FITC-dextran across intestinal explants.
Treatment Mean fluorescence intensity after DON
treatment
1 h 2 h
Control 4.3±0.5 11.3±1.4
5 μM DON 5.5±0.6 11.7±1.7
20 μM DON 8.7±1.1⁎⁎ 19.8±2.4⁎⁎
50 μM DON 7.9±0.9⁎⁎ 19.0±2.9⁎
Explants of porcine jejunum were mounted in Ussing chambers before adding 0 to
50 μM DON and FITC-dextran in the mucosal compartment. At 1 and 2 h, the serosal
compartment was collected to assess the fluorescence. Data are expressed as mean
fluorescence intensity, after deduction of the background±SEM of 6 to 8 independent
experiments.
Student's t-tests were performed to determine the effect of DON treatment: ⁎Pb0.05,
⁎⁎Pb0.01.
2004; Schneeberger and Lynch, 2004). Caco-2 and IPEC-1 cells, grown
and differentiated on inserts, were treated with 0 or 30 μM DON for
48 h, then stained for ZO-1, occludin, claudin-3 or 4. As expected,
localization of the tight junction proteins showed strong peripheral
labeling in control Caco-2 and IPEC-1 cell monolayers. The overall
morphology of DON-treated cells was unchanged. ZO-1 as well as
occludin staining and localization were unaffected by DON treatment,
irrespective of the cell line considered (Fig. 3). In contrast, DON
treatment strongly reduced the intensity of the staining for claudin-3
in Caco-2 cells (Fig. 3A) and for both claudin-3 and claudin-4 in IPEC-1
cells (Fig. 3B). No increase of immunofluorescent signal was observed
in other area of the cells, suggesting that, rather than being
relocalized, claudins were removed from the cell tight junctional
complexes.
This hypothesis was tested by western blot analysis with
antibodies for claudin-3, claudin-4 and β-actin (Fig. 3). Densitometric
analysis of the immunoblots revealed that in Caco-2 cells the signal for
claudin-4 was reduced by 48% (Pb0.001) in DON-treated samples
Fig. 3. Effect of DON on the expression of tight junction proteins on intestinal cell monolayers. Human Caco-2 cells (panel A) or porcine IPEC-1 cells (panel B) were grown and
differentiated on inserts and treated for 48 h with 30 μM DON. Upper panel illustrates immunocytochemistry experiments: cells were stained with antibodies for occludin, ZO-1,
claudin-3 and claudin-4. Confocal images (z=0.5 μm)were acquired using constant parameters (upper panel). The bar represents 10 μm.Middle and lower panels illustrate western
blotting experiments: cells were scraped, lysed, and 15 μg of proteins was analyzed by immunoblotting with antibodies for claudin-3 and claudin-4 and β-actin as a protein loading
control. The expression of the proteins was estimated by densitometry after normalization with β-actin signal and presented as mean±SEM of 5 independent experiments. Middle
panel represents the immunoblots and lower panel the densitometric analysis of control (open bars) and DON-treated (closed bars) samples. Student's t-tests were performed to
compare control and DON-treated samples: ⁎⁎Pb0.01; ⁎⁎⁎Pb0.001.
when compared with untreated ones. In this cell line, the signal for
claudin-3 remains unchanged in control and treated cells. In IPEC-1
cells, the signals for both claudin-3 and claudin-4 were reduced in
DON-treated samples when compared to untreated samples (claudin-
3: −67%, P=0.0011; claudin 4: −60%, Pb0.001).
In vivo, exposure to DON-contaminated diet also significantly
reduced claudin-4 expression. Pigs received for 5weeks, either control
non contaminated feed or feed contaminated with 2.85 mg/kg DON.
Western blot analysis of jejunum samples revealed a 40% decrease of
claudin-4 expression in samples obtained from DON exposed animals
when compared with controls ones (Fig. 4A). This reduction was
confirmed by immunohistochemistry, and was more pronounced in
the intestinal villi than in the crypts (Fig. 4B).
We demonstrated that DON selectively decreases the expression of
the claudins tight junction proteins in intestinal epithelial cells treated
with the toxin as well as in the jejunum of animals exposed to DON-
contaminated feed.
Discussion
An important function of gastrointestinal epithelia is to provide a
barrier against the penetration of food contaminants and pathogens
present in the intestinal lumen. The disruption of the intestinal barrier
allows increased penetration of normally excluded luminal substances
that may promote intestinal disorders (Arrieta et al., 2006; Oswald,
2006). In the present study we demonstrated that DON alters claudin
expression and decreases the barrier function of the intestinal
epithelium.
DON is a common contaminant of cereal grains encountered
worldwide (CAST, 2003). For example, US Federal Grain Inspection
Service or European Union surveys have shown significant levels of
DON contamination in raw cereals: up to 50 mg/kg in wheat, 26 mg/
kg in barley and 19mg/kg in cornmeal (SCOOP, 2003; Trucksess et al.,
1995; Abouzied et al., 1991). In the present study, concentrations
demonstrating an effect on intestinal barrier ranged between 5 and
30 μM. Assuming that DON is ingested in one meal, diluted in 1 L of
gastrointestinal fluid and is totally bio accessible (Sergent et al., 2006),
the in vitro concentrations used in this study correspond to food
contamination ranging from 1.5 to 10 mg/kg. A similar approach has
already been used in DON or ochratoxin A studies (Sergent et al.,
2006).
In the present study, we extend to a non-transformed porcine
intestinal epithelial cell line the finding that DON decreases in a dose
and time dependant manner the TEER, a good indicator of the
epithelium integrity. Beside DON, other mycotoxins such as Ochra-
toxin A, Patulin, or Fumonisin have been shown to decrease the TEER
of epithelial cells (Bouhet et al., 2004; McLaughlin et al., 2004;
Maresca et al., 2008). The observed reduction in TEER can be due to an
alteration of the tight junction barrier properties but also to an effect
on plasmamembrane such as differences in transcellular ion transport
(Barrett, 1993). As we observed that DON increases the permeability
of Caco-2 and IPEC-1 cells to a 4 kDa paracellular tracer and decreases
the expression of claudins, we would favor the hypothesis of an action
on the tight junctions.
Using porcine explants, we were able to extrapolate the effect of
DON on paracellular permeability from in vitro culture to tissue
explants. Intestinal mucosal permeability from the pig correlated with
those of human (Nejdfors et al., 2000). We further confirmed that
DON affects the expression of tight junction protein on jejunal section
obtained from piglets exposed to contaminated feed. Among animal
species, pig shows great sensitivity to DON, moreover, pig can be
regarded as a good model of extrapolation to humans (Rothkotter et
Fig. 4. Effect of DON exposure on the expression of claudin-4 in the jejunum. Midjejunal tissues were obtained from pigs fed for 5 weeks with mycotoxin-free or DON-contaminated
feed. Panel A (immunoblotting): Proteins were extracted from frozen tissue and 15 μg of proteins was analyzed by immunoblotting with antibodies for claudin-4 and β-actin as a
protein loading control. The expression of the proteinswas estimated by densitometry after normalizationwith β-actin signal and presented asmean±SEM of 5 control and 5 treated
animals. Student's t-tests were performed to compare control and DON-treated samples: ⁎⁎⁎Pb0.001. Panel B (immunocytochemistry): Paraffinwax-embedded jejunum fragments
were obtained from control and DON-treated animals, 5-μm-thick sections were stained with antibody for claudin 4 and counterstained with Mayer hematoxylin.
al., 2002; Almond, 1996). As we observed an effect of DON on human
and porcine intestinal cell lines as well as on porcine explants, we can
make the hypothesis that intestinal barrier function is also decreased
in human or animals eating DON-contaminated food/feed.
A higher sensitivity to DON, as measured by TEER, paracellular
permeability and claudin expression, was observed in IPEC-1 cells
when compared to Caco-2. Several hypotheses could explain this
higher sensitivity of IPEC-1 cells. First, Caco-2 cells were obtained
from an adenocarcinoma whereas IPEC-1 cells were derived from
normal newborn piglet (Gonzalez-Vallina et al., 1996). Second, even if
Caco-2 cells express morphological and biochemical characteristics of
small intestine (Pinto et al., 1983), they are derived from the colon. By
contrast, IPEC-1 cells were obtained from jejunum and ileum. Third,
these two cells line are from different species (pig versus human).
Among animal species, pig is the most sensitive species to DON
however it is difficult to assess the susceptibility of humans (Pestka
and Smolinski, 2005). Our study demonstrates that IPEC-1 cells
represent a very sensitive cellular model to investigate the effect of
food contaminants.
The decreased barrier function (TEER and paracellular flux) was
associated with an increased translocation of a pathogenic E. coli
across the IPEC-1 cell monolayers. Using a laboratory K12 strain of E.
coli, an increase translocation across Caco-2 cell monolayers was also
demonstrated (Maresca et al., 2008). It would be important to extend
this observation using a non-domesticated pathogenic strain of
porcine (clinical) origin. Indeed, the E. coli taxon is highly versatile;
the genome difference between a laboratory-adapted strain and a
pathogenic clinical strain can reach as much as 60% (Welch et al.,
2002) and it is recognized that a laboratory K-12 strain does not
represent the archetypal, “normal” E. coli (Hobman et al., 2007).
As previously observed during metabolic stress, interferon-γ
treatment or hypoxia (Tazuke et al., 2003; Clark et al., 2005; Nazli et
al., 2006), DON treatment causes an increase in the translocation of
bacteria across intestinal epithelia. This increase in the bacterial
translocation following DON treatment could have major implications
for human and animal health in term of susceptibility to infection as
well as inflammation and sepsis. Moreover, as a synergistic toxicity
between DON and LPS as been described, especially when looking at
the secretion of inflammatory cytokines (Islam and Pestka, 2006; Van
De Walle et al., 2008), we predict that translocated bacteria may
amplify the intestinal toxicity of DON.
In mice, DON-contaminated diet accelerates Salmonella enteritidis
infection (Hara-Kudo et al., 1996) and transiently increases the
severity of reovirus infection (Li et al., 2005). In addition, inflamma-
tory bowel diseases, such as Crohn's disease, are generally associated
with an increased passage of bacteria through the gut epithelium
because of a defective epithelial barrier function (Martin et al., 2004;
Sasaki et al., 2007; Weber and Turner, 2007). It might be speculated
that, at least in some cases, ingestion of DON-contaminated food could
be involved in inducing inflammatory bowel disease.
Decreased TEER and increased FITC-dextran permeability sug-
gested modifications of the tight junction complex (Madara, 1998).
Confocal views of DON-treated cells stained for tight junction proteins
showed a large reduction in the intensity of the junctional staining for
claudins but not for ZO and occludin. No relocalization of the
fluorescent signal to other cellular areas was observed, suggesting
that claudins had disappeared from the cells. Consistent with this
observation immunoblotting results demonstrate a reduction in the
levels of claudins. The overall morphology of the cells was unchanged
by DON treatment, suggesting specific effects on claudins rather than
gross changes to the cells. At the tissue level, the decrease of the
expression of claudin-4 in response to DON treatment was more
important in villi than in crypts. Regarding the specific effect of toxin
on claudin expression, similar results have been observed with
Ochratoxin A, another mycotoxin (McLaughlin et al., 2004) and
enterotoxin A from Clostridium perfringens (Sonoda et al., 1999). The
specific removal of claudin from intercellular junctional complexes
also suggests that the presence of ZO-1 and occludin alone in the tight
junctions may not be sufficient to achieve a paracellular seal in
intestinal epithelial cells.
As we observed that, in intestinal tissues, DON concurrently
decreases barrier function and reduces the expression of claudin, we
canmake the hypothesis that, among other tight junction proteins, the
specific decrease of claudin expression is responsible for the increase
of intestinal barrier permeability. This mechanism as already been
suggested in cultured cells for the increase permeability of canine
intestinal epithelial cells exposed to Campylobacter jejuni (Lamb-
Rosteski et al., 2008) and for the decrease of the barrier function of
Caco-2 cells treated with Ochratoxin A (McLaughlin et al., 2004). In
human biopsies, down-regulation of claudin-4 and claudin-7, and up-
regulation of claudin-2 was observed in active ulcerative colitis and
might lead to altered TJ structure and impaired epithelial function
(Oshima et al., 2008).
Tight junction structure and function can be regulated by signaling
molecules involved in MAPK pathways (Matter and Balda, 2003) and
DON is known to rapidly activate MAPK (Pestka et al., 2004). Thus, we
can make the hypothesis that activation of MAPK, as a consequence of
DONexposure, decreases the expressionof tight junctionprotein suchas
claudin-4 which in turn reduces the barrier function of the intestine
evaluated by TEER, paracellular permeabilityandbacterial translocation.
This study, along with previous ones, strengthens the concept that
intestinal epithelial cells are important targets for the toxic effects of
mycotoxins (Bouhet et al., 2004, 2006; Yang et al., 2009). Considering
that high levels of DON may be present in animal feeds and human
food, chronic consumption of DON-contaminated food or feed can
induce intestinal damage and may have consequences for animal and
human health. Further epidemiological studies are needed to assess
the extent to which DON may be involved in the development of
infectious diseases in humans and animal.
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